If you've been following the news of NIH-funded researchers seemingly entangled in webs of unreported, underreported, or misreported financial ties to industry over the past year or so, you know that the buck often stops at the desk of linkurl:Sen. Charles Grassley;http://www.the-scientist.com/blog/display/54832/ (R-IA). You might have also noticed that many of the subjects of Grassley's recent inquiries are psychiatrists who are funded by NIH's National Institute of Mental Health (NIMH). In fact, of the past eight researchers investigated by Grassley over the last year, at least six have been NIMH grantees. The most prominent of these was Stanford researcher Alan Schatzberg, president-elect of the American Psychiatric Association, who Grassley linkurl:accused;http://www.the-scientist.com/blog/display/54771/ of failing to disclose owning millions of dollars of stock in the company that produces mifepristone (otherwise known as linkurl:RU-486,;http://www.the-scientist.com/article/display/10905/ the "abortion pill"). Schatzberg was the principal investigator on an NIMH grant to study the drug's effectiveness in treating depression....
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?